Cost-effectiveness analysis of pre-exposure prophylaxis for the prevention of HIV in men who have sex with men in South Korea: a mathematical modelling study

In February 2018, the Ministry of Food and Drug Safety in Korea approved tenofovir disoproxil fumarate and emtricitabine (TDF/FTC) co-formulate for use in pre-exposure prophylaxis (PrEP) for the prevention of human immunodeficiency virus (HIV) infection. This study aimed to estimate the cost-effecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Heun, Suh, Jiyeon, Lee, Woonji, Kim, Jun Hyoung, Kim, Jung Ho, Seong, Hye, Ahn, Jin Young, Jeong, Su Jin, Ku, Nam Su, Park, Yoon Soo, Yeom, Joon Sup, Kim, Changsoo, Kwon, Hee-Dae, Smith, Davey M., Lee, Jeehyun, Choi, Jun Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471951/
https://www.ncbi.nlm.nih.gov/pubmed/32884082
http://dx.doi.org/10.1038/s41598-020-71565-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471951/
https://www.ncbi.nlm.nih.gov/pubmed/32884082
http://dx.doi.org/10.1038/s41598-020-71565-y

Ejemplares similares